Analyzing Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP)
Head-To-Head Survey: MiniMed Group (NASDAQ:MMED) versus Longevity Health (NASDAQ:XAGE)
Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) Financial Comparison
Financial Analysis: Check-Cap (NASDAQ:MBAI) & Longevity Health (NASDAQ:XAGE)
Analyzing Predictive Oncology (NASDAQ:AGPU) & Longevity Health (NASDAQ:XAGE)
Why Longevity Health Stock Is Skyrocketing Today
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
Longevity Health Holdings Announces Business Updates
Longevity Health Holdings, Inc. Announces Reverse Stock Split
CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
Carmell Announces Closing of Elevai Skincare Acquisition
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
Carmell Announces Successful Closing of $3.0 Million Private Placement
Carmell Announces $3.0 Million Private Placement
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
Best Penny Stocks To Buy? 6 To Watch Before Next Week